newsroom

FiTalent (FIT-II) invests in Medibiofarma, a Spanish biotechnology company founded in 2016 by a group of professionals with extensive experience in Drug Discovery in pharmaceutical industry. The company´s aim is generating innovative and high quality pharmaceutical research programs based on the modulation of clinically validated therapeutic targets for the treatment of cancer and neurodegenerative diseases.

FiTalent (FIT-II) invests in Ability Pharma, a clinical-stage biopharmaceutical company focused on developing first-in-class causing autophagy molecules through binding to the nuclear receptors PPARα and PPARγ and inducing Reticular Stress (ER-Stress). It represents a novel approach, offering an opportunity to create important new therapeutic options for cancer patients

IciRed is the first online platform of commercial incidents due to default that attacks online reputation and the fingerprint of companies that do not meet their contractual commitments and resort to non-payment of accumulated invoices.

Operator of operators that is born to replace the deficiencies that the great telecommunications operators have in populations of less than 25,000 inhabitants.

FiTalent (FIT-II) invests in Boxmotions, a company that introduces a new concept of storage (“we collect your stuff for free, we store it and bring it to you anytime”)